Cityslicker wrote - I'm not very surprised it was pulled. Don came scross as too confident for my liking, making statements that could not be justified. He didn't sound like a CEO of a biotech company, more like a salesman. Such a pity that a drug with such great prospects is in his hands. But I have just read the recent papers in Cell and Biomedicine again, and older papers showing reduced IL-1beta effect (driver of cytokine storms). The data are very impressive. That's what really matters. So plenty to be positive about. I can't imagine a drug with better credentials for a covid trial. 

Your thoughts sum up my feelings precisely. Most of this presentation was about science. It stirkes me that RVX employs some very talented scientists either directly of indirectly. It would a wonderful opportunity to showcase the scientific stars that have lead to the development of apabetalone and other, possibly breakthrough, compounds. I think showcasing Dr Kulikowski or Dr Sweeney would have a very positive impact on the RVX brand in terms of believability and trust. Investors may gain a more credible feeling about the brand. 

The part in the presentation where I felt Don's nose starting to grow was at the following question.

Q: So again on the BETonMACE trial, do you have any large pharmaceutical companies partnering with you on this one?

A: We will be working with a very sophisticated group on that and we will announce that later. That’s not public information yet, but the answer is yes.

Note that Don said "will be working" meaning they are not now working with whomever at this time. At this point Don seemed to pause or hesitate as if he was caught of guard. This  is where he turned secretive again. To give him the benefit of the doubt if he is referring to a Rothchild or a large well known M & A company then I'd be somewhat reassured, but it's a secret   :)

So  my opinion is "we'll see". Don has been very successful in teaching me to not trust him.

That being said I am very pleased (thrilled) to be holding shares in one of the worlds best kept secrets and I appreciate the buying opportunity that currently exists.

The business side of this company is a mess as evidenced by recent financings, putting the IP into a tenuous position again and lack of finding a partner for BoM2, etc but strangely I'm not worried about my investment.

From my POV it's all about Covid at this stage.

GLTA

Toinv